2-Deoxy-D-Glucose (2-DG)
Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet
5
Original Article Protective effects of 2- deoxy-D-glucose on nephrotoxicity induced by cyclosporine A in rats
9
Increased Thirst and Plasma Arginine Vasopressin Levels during 2 Deoxy d glucose induced Glucoprivation in Humans
12
Meta Analysis to Determine the Diagnostic Value of 2 18Fluoro 2 Deoxy D Glucose Positron Emission Tomography in Assessing Residual Tumors after Systemic Therapy for Metastatic Seminoma
6
Incidentalomas of the prostate detected by 18 fluoro 2 deoxy D glucose positron emission tomography/computed tomography
12
THE EFFECT OF 2 DEOXY D GLUCOSE INFUSIONS ON LIPID AND CARBOHYDRATE METABOLISM IN MAN
7
Induction of Type C Virions from Normal Rat Kidney Cells by 2-Deoxy-d-Glucose
8
Biological and physical modifications of a murine oncornavirus by 2-deoxy-D-glucose.
9
Detectability of Hypometabolic Regions in Mild Alzheimer Disease: Function of Time after the Injection of 2 [Fluorine 18] Fluoro 2 Deoxy d Glucose
5
Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer
7
Inhibition of Herpes Virus-Induced Cell Fusion by Concanavalin A, Antisera, and 2-Deoxy-d-Glucose
8
Effect of 2-deoxy-D-glucose on herpesvirus-induced inhibition of cellular DNA synthesis.
5
Inhibition of the Multiplication of Vesicular Stomatitis and Newcastle Disease Virus by 2-Deoxy-d-Glucose
8
Chronic expanding hematoma with a significantly high fluorodeoxyglucose uptake on 18F fluorodeoxyglucose positron emission tomography, mimicking a malignant soft tissue tumor: a case report
5
Cholangiocarcinoma associated with limbic encephalitis and early cerebral abnormalities detected by 2 deoxy 2 [fluorine 18]fluoro d glucose integrated with computed tomography positron emission tomography: a case report
6
2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
9
Positron emission tomography agent 2 deoxy 2 [18F]fluoro D glucose has a therapeutic potential in breast cancer
7
Standardised uptake values of 2 deoxy 2 [18F]fluoro d glucose using PET/CT in normal cats
9
An improved synthesis and preliminary biodistribution study of a Technetium-99m-labeled 2-amino-2-deoxy(thioacetyl)-D-glucose complex ([99mTc]-TA-DG) as a tumor imaging agent
6
Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation
10